Form 8-K - Current report:
SEC Accession No. 0001804585-23-000007
Filing Date
2023-04-07
Accepted
2023-04-10 11:57:36
Documents
1
Period of Report
2023-03-03
Items
Item 5.01: Changes in Control of Registrant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K plain8k.txt 8-K 8067
  Complete submission text file 0001804585-23-000007.txt   9200
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

EIN.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56153 | Film No.: 23810248
SIC: 2834 Pharmaceutical Preparations